Xpress Biologics is a contract development organization specialized in the production of Biologics (recombinant proteins, antibody fragments and plasmid DNA), for preclinical applications specific to the therapeutic and diagnostic markets. Its mission is to enable the transition of the projects from R&D to clinical manufacturing. Both, the production scale (from 100 mg up to 50 g) and the quality of the biologics (R&D and GLP grade material) proposed by Xpress Biologics are adapted for in vitro and in vivo pre-clinical validation of the biologics (proof-of-concept, early safety, potency, efficacy…). Moreover, Xpress Biologics processes are free of charge in terms of license or royalty fees and take into account the industrial (scale-up) and regulatory requirements, including the development of the quality controls, which greatly facilitates the transfer of the project to CMOs (Contract Manufacturing Organizations) for the production of GMP grade material.
Xpress Biologics acts as One-Stop-Shop and can, through project management with defined subcontractors, take in charge additional services as the production of GMP grade material.